FDA Targets Telehealth Drug Marketing After Biden’s FDA Said It Lacked Authority

By Cara Smith / September 17, 2025 at 5:50 PM

Over a dozen telehealth companies received warning letters from FDA’s drug center -- including popular platform Hims & Hers -- flagging ads for weight-loss drugs the agency says are “false and misleading” and violate the Federal Food, Drug, and Cosmetic Act.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.